peplomycin , derivative of bleomycin which was developed because of a lower pulmonary toxicity and broader anti-tumor spectrum in animal study , also showed to be effective in clinical studies on adenocarcinomas such as prostatic cancer , breast cancer , etc . as well as on squamous cell carcinoma and the anti-tumor spectrum were observed to be broader than those of bleomycin .
C0007137
squamous cell carcinoma
C0005740
bleomycin